Monopar Therapeutics
MNPR
#8577
Rank
HK$1.05 B
Marketcap
HK$200.70
Share price
8.53%
Change (1 day)
1,191.39%
Change (1 year)

Revenue for Monopar Therapeutics (MNPR)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Monopar Therapeutics from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA